Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
about
Advancing clinical development pathways for new CFTR modulators in cystic fibrosisCFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosisPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.The lung mycobiome: an emerging field of the human respiratory microbiome.Central Role of IL-23 and IL-17 Producing Eosinophils as Immunomodulatory Effector Cells in Acute Pulmonary Aspergillosis and Allergic Asthma.New Commercially Available IgG Kits and Time-Resolved Fluorometric IgE Assay for Diagnosis of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis.IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisPathogenesis of Fungal Infections in Cystic Fibrosis.A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis.Burden of serious fungal infections in the Czech Republic.Serious fungal diseases in the Republic of Uzbekistan.Serious fungal infections in Portugal.Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic FibrosisAspergillus fumigatus in cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis.Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes.An estimate of the burden of serious fungal diseases in Greece.Dirhamnolipids secreted from Pseudomonas aeruginosa modify anjpegungal susceptibility of Aspergillus fumigatus by inhibiting β1,3 glucan synthase activity.Burden of serious fungal diseases in Hungary.Estimated burden of fungal infections in Germany.The burden of fungal disease in Denmark.Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis.The ambitious '95-95 by 2025' roadmap for the diagnosis and management of fungal diseases.Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis.Burden of Severe Fungal Infections in Burkina Faso.Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity.An Estimate of the Burden of Fungal Disease in Norway.An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan.Estimated Burden of Serious Fungal Diseases in SerbiaFungi in Cystic Fibrosis: Recent Findings and Unresolved Questions
P2860
Q26768266-26DD8D2B-4328-4A99-B397-BCF61EC5244AQ28073996-E3482798-BCD8-49FA-A262-5B00F763E4D4Q30244524-44E47E29-D8E4-4136-81F8-A94436835B07Q33810871-A03AAF3C-607B-4E17-BA5C-3EA687795675Q34532546-5AF7879E-0EBF-4A21-BE72-7DCC402F928CQ35082308-CB71CA64-968B-4A61-8D3A-2A31B46E18F1Q36251378-44C34357-6C97-437D-A4DD-11B36059FEF5Q36665650-87E3501C-8603-4005-87C1-CE2AC0CE406EQ36690556-70303DB4-0A33-461C-B9DE-19704C678151Q37500602-EBA4CE18-0FE4-4F82-AB75-11E6B22521A7Q37591319-89B77D94-C37E-4B8E-93D9-751C804D7CD8Q38547759-02D90E3F-3022-4C8D-A7ED-2E04F52EF892Q38602634-96824205-12B3-4A16-9633-74B55F906C19Q38907928-0521256B-0E2E-46A0-A1D8-FF46C1894655Q38966457-43A56DAC-0D19-4BCC-A63B-0C9F9EDEFF73Q39253846-14DF6758-0105-497F-AB83-0DC251871E6CQ39312862-EF6B31F2-EEA1-4645-8DF4-CC62BFD9F3A1Q39669137-06AACC6B-E4DD-4C92-BDC2-DE5CFE59A17FQ39845050-24750DAF-186A-4DC1-B05D-A163F8559186Q40280045-D2CCE54F-74AF-4FC1-AD99-76EC500B9905Q40451803-91A2F50D-27CA-4322-8BC8-5686B345073FQ40451809-EC48ACE1-CA8F-45B6-ADD1-47FAC5D63BFAQ40451819-8C257876-A0BD-4CDC-A455-0A61907CFA20Q40616179-794D2C76-99DA-4655-A302-701EC360F8C6Q43570859-C1DB4DF7-88FC-442E-8FE9-B6C4CCF8979FQ47646997-D8C85C41-F20E-4687-9BED-F79B78987116Q47742553-4A088C68-7165-435B-BD2E-04D9B42360FEQ52657741-AB837FA1-6BE4-48F8-88FC-0AEEC251818BQ53830506-6ED79E5B-88D8-4555-90E4-20E2FF6B0BEFQ54269444-B332E74B-FD5F-4D6B-8564-2A5187E538F5Q55069304-EB5A2C56-CBAF-42A3-B789-1F0E573F9945Q56837188-8FA83FC3-18EE-427F-9285-0F2FB52233F2Q58817590-938688D1-0225-47AE-891F-9C491E3B2D64
P2860
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@ast
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en-gb
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@nl
type
label
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@ast
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en-gb
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@nl
altLabel
Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis
@en
prefLabel
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@ast
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en-gb
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@nl
P2860
P3181
P1433
P1476
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis
@en
P2093
Joanne Armstead
Julie Morris
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0098502
P407
P577
2014-01-01T00:00:00Z